Literature DB >> 19996831

Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.

Dong Ho Park1, In Taek Kim.   

Abstract

PURPOSE: The purpose of this study was to evaluate the long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion (CRVO) and hemiretinal vein occlusion (HRVO).
METHODS: Best-corrected visual acuity, central foveal thickness by optical coherence tomography, and fluorescein angiography were evaluated retrospectively in 20 patients (20 eyes). The mean follow-up time was 61.2 months. Pars plana vitrectomy and internal limiting membrane peeling using indocyanine green staining were performed in all patients.
RESULTS: Preoperative mean central foveal thickness of all 20 eyes decreased significantly by 6 months, and this reduction was maintained until 60 months. The mean central foveal thickness of the group with perfused type CRVO, ischemic type CRVO, and HRVO at 6 months significantly decreased from the preoperative value, and the significant reduction was maintained until 60 months. Best-corrected visual acuity of the perfused CRVO and HRVO groups tended to improve in contrast to the ischemic CRVO group postoperatively. Best-corrected visual acuity of the perfused CRVO group at 24 months or later was significantly improved from preoperative best-corrected visual acuity.
CONCLUSION: Pars plana vitrectomy with internal limiting membrane peeling in eyes with macular edema secondary to CRVO and HRVO produces an anatomical improvement, which persists up to 5 years, and a best-corrected visual acuity improvement, at least in perfused CRVO and HRVO.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19996831     DOI: 10.1097/IAE.0b013e3181bced68

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  16 in total

Review 1.  Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

Authors:  Tasanee Braithwaite; Afshan A Nanji; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  Is traction the cause or the effect?

Authors:  David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-12       Impact factor: 3.117

3.  Comparison of anti-vascular endothelial growth factors, laser treatments and a combination of the both for treatment of central retinal vein occlusion.

Authors:  Yoav Y Pikkel; Adi Sharabi-Nov; Itzchak Beiran; Joseph Pikkel
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

Review 4.  Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.

Authors:  Tasanee Braithwaite; Afshan A Nanji; Kristina Lindsley; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2014-05-01

5.  Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography.

Authors:  Michael R Martinez; Avinoam Ophir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-07       Impact factor: 3.117

6.  Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.

Authors:  Minhee Cho; Donald J D'Amico
Journal:  Clin Ophthalmol       Date:  2012-07-06

Review 7.  Complications of Macular Peeling.

Authors:  Mónica Asencio-Duran; Beatriz Manzano-Muñoz; José Luis Vallejo-García; Jesús García-Martínez
Journal:  J Ophthalmol       Date:  2015-09-03       Impact factor: 1.909

8.  Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion.

Authors:  Seong Joon Ahn; Jeeyun Ahn; Se Joon Woo; Kyu Hyung Park
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

9.  Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome.

Authors:  Joseph Pikkel; Otzem Chassid; Yumna Busool; Ward Srour; Adi Sharabi-Nov; Itzchak Beiran
Journal:  J Ophthalmol       Date:  2013-12-29       Impact factor: 1.909

Review 10.  Inflammation and macular oedema after pars plana vitrectomy.

Authors:  Vito Romano; Martina Angi; Fabrizio Scotti; Renata del Grosso; Davide Romano; Francesco Semeraro; Paolo Vinciguerra; Ciro Costagliola; Mario R Romano
Journal:  Mediators Inflamm       Date:  2013-10-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.